Funding R&D: High Prices, Overuse A Failed Strategy

May 14, 2012
GoozNews
By Merrill Goozner

Much has been written about the travails of the pharmaceutical industry. Generic competition is reducing profitability as leading blockbuster drugs like Pfizer’s Lipitor lose patent protection. Biotech generic competition is on the horizon. Read more

Also In The News

Tell Us Your Thoughts

How do you feel about having to pay more than everyone else for your medication? Tell us your story. **By filling out this form you are giving RxRights permission to use your comments to help build support for safe, affordable drug importation.**